Oligonucleotide Synthesis Market

Global Biologics Market To Be Driven By Rising Investments In Research And Development (R&D) Activities In The Forecast Period Of 2022-2027

The new report by Expert Market Research titled, ‘Global Biologics Market Report and Forecast 2022-2027’, gives an in-depth analysis of the global biologics market, assessing the biologics market based on its segments like sources, product types, manufacturing, disease categories, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.

Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/biologics-market/requestsample

The key highlights of the report include:

Market Overview (2017-2027)

  • Forecast CAGR (2022-2027): 4.1%

Geographically, North America occupies a significant share in the market growth of biologics. This is supported by the presence of several leading companies and the subsequent rising investments in the R&D sector. Meanwhile, the Asia Pacific region is expected to make significant contributions to the market in the coming years owing to the developing healthcare sector in the region. Further, the market is anticipated to be driven by the dominance of microbial sources as a major portion of the product range has its source in the microbial expressions system, which are used during the treatment of several chronic diseases depending upon the type of monoclonal antibodies. The market is being further driven by the products used in cancer treatment applications.

Industry Definition and Segmentation

Biologics are defined as disease-modifying antirheumatic drugs (DMARDs). Also known as biological drugs, these are made from living organisms or consist of their components, such as blood, cells, genes, tissues, allergens, and recombinant proteins. These drugs control the production of vital proteins, and aid in the modification of human hormones and cells while producing substances to activate and suppress the immune system.

On the basis of source, the market can be divided into:

  • Microbial Source
  • Mammalian Source
  • Others

Based on product type, the market can be classified into:

  • Monoclonal Antibodies
  • Murine MABs
  • Chimeric MABs
  • Humanised MABs
  • Human MABs
  • Others
  • Vaccines
  • Recombinant Proteins
  • Antisense, RNAi and Molecular Therapy
  • Others

The market, based on manufacturing, can be distinguished into:

  • Outsourced
  • In-house

On the basis of disease category, the market is segmented into:

  • Oncology
  • Infectious Disease
  • Immunological Disorders
  • Cardiovascular disorders
  • Haematologic Disorders
  • Others

The regional markets for biologics include:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Market Trends

The growth in the global market for biologics is being driven by the exceeding cases of chronic disorders. As a result, the increase in demand for efficient diagnostics and treatment drugs is pushing the market growth of biologics. Further, the year-by-year increase in cancer patients is propelling the need to modify therapies and introduce drugs that can enhance the immune system and destroy cancer-causing cells at the earliest. This demand is likely to boost the market growth of biologics in the coming years. The growing research and development (R&D) activities by prominent market leaders are backed up by government initiatives and investments.

Key Market Players

The major players in the market are Samsung Biologics, Amgen Inc., Novo Nordisk A/S, Pfizer Inc., Merck & Co., Inc., Precision Biologics, Inc., and F. Hoffmann-La Roche AG, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Media Contact

Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

About louiswane

The Sandwich Panels Market is also to be driven by the ample advantages offered by their usages, such as fast and easy installation, thermal insulation, the aesthetic appearance of the building, high fire resistance, prevention from water leakage, and noise-free buildings. Read More: Sonobuoy Market, Hub Motor Market, Europe Biodiesel Market

Check Also

Top 5 Benefits of Acne Laser Treatment

Acne is a common skin condition that affects millions of people worldwide, causing distress and …

Leave a Reply

Your email address will not be published. Required fields are marked *